Standout Papers

Oxaliplatin: A review of preclinical and clinical studies 1998 2026 2007 2016 511
  1. Oxaliplatin: A review of preclinical and clinical studies (1998)
    Éric Raymond, Stephen G. Chaney et al. Annals of Oncology

Immediate Impact

19 by Nobel laureates 18 from Science/Nature 70 standout
Sub-graph 1 of 19

Citing Papers

Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
2021 Standout
Ribosome biogenesis in cancer: new players and therapeutic avenues
2017 Standout

Works of Stephen G. Chaney being referenced

p53 and p21 Regulate Error-Prone DNA Repair to Yield a Lower Mutation Load
2006
Cellular and molecular pharmacology of oxaliplatin.
2002

Author Peers

Author Last Decade Papers Cites
Stephen G. Chaney 3121 3475 821 102 5.7k
Isabelle Martins 2972 2973 857 76 7.5k
Caroline J. Springer 6552 3115 654 126 8.8k
Žaklina Kovačević 3167 1759 635 87 5.5k
Graziella Pratesi 3637 3811 1057 147 6.6k
Patric J. Jansson 2529 2320 459 85 5.3k
Gavin P. Robertson 4658 1962 1224 126 7.0k
Mark J. McKeage 1619 3260 496 142 5.4k
Paola Perego 5682 4102 1514 176 8.9k
Michelle D. Garrett 6007 2985 936 112 8.5k
Dong‐Hua Yang 3119 2037 773 182 5.5k

All Works

Loading papers...

Rankless by CCL
2026